In contrast to universalist models of agent-identification in philosophy and psychology, the novelty of the psycho-historical framework is the inclusion of an ontological component that refers to the historical ontology of the target of agent-identification behaviours.
Recently, many studies put the sights into genomic polymorphisms in genes involved in drug metabolic pathway and correlated with the target of agents.
Proto-oncogenes, which encourage cell growth, and tumour suppressor genes, which inhibit it, are frequent targets of agents known to cause cancer, including chemicals, viruses, and radiation.
It has been shown that the targets of agents are an important factor for the formation of effective drug combinations [ 9].
Some of the genes selected are targets of agents that have not been tested for efficacy in combination with paclitaxel in the preclinical setting and are of biological relevance and interest (for example, transforming growth factor beta (TGFβ) signaling).
Biologic agents can facilitate the dissection of the role played by the target of the agent in the disease process.
Finally, the signature analysis could reveal target "pathways" of each agent, but the analysis would not be enough to completely define target "molecules" of the agent (for example, inhibitors of mitotic pathways showed similar gene signatures despite the direct target of each agent being different).
Furthermore, organs belonging to the immune system (spleen, thymus, bone marrow) appear to be another target of this agent [19], [20].
As shown in Fig. 4 A & B, oxygen consumption was inhibited more at the level of CII, the target of the agent.
Further studies using radiolabelled 3-BrPA have identified the glycolytic enzyme GAPDH as the primary intracellular target of this agent [ 84].
About half of the target of 445 agents have completed the training, Reuters reported that he said.
